O
Power Law company profile
OliX Pharmaceuticals
Biotech & Life Sciences · Suwon, South Korea · Founded 2010 · IPO 2018 Unicorn
Valuation
$3.02B
Market cap · Apr/2026
Revenue
$12M
Latest reported FY
Global footprint
Where OliX Pharmaceuticals has talent and traffic
Web traffic by country
29K
monthly visits
across markets
across markets
🏳️ Korea107.6%
🏳️ Republic of3.4%
🇺🇸 United States0%
Patent intelligence
$49M patent portfolio · 36 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$49M
1.6% of market cap · 5.6× smaller than top peer argenx ($275M)
36 active patent families
Where OliX Pharmaceuticals innovates
Molecular biologyRNAMoietyNucleotideMacromolecule
Above peer median on Legal, Market
Quality vs same-sector peers
OliX Pharmaceuticals on the five Patsnap quality dimensions
OliX Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where OliX Pharmaceuticals concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across OliX Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee OliX Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.